SP7 and ocular melanoma: Indeed, BMSC treated with Treg-CM showed significant upregulation of early differentiation marker (SP7), followed by the upregulation of late-stage marker (SPP1) compared to those treated with Non-CM and OM; highlighting the impact of Treg-CM on both early and late stages of osteogenesis.